Thoracic oncology has been transformed by discoveries that seemed impossible just a couple decades ago. Lung cancer classification has shifted from histology to molecular drivers that directly determine treatment. Immune checkpoint inhibition has moved from metastatic disease to intent-to-cure, and into the neoadjuvant setting.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Sharon R.
Contact Sharon R., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack